Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study.
Adrien ContejeanCécile JanssenFrédérique Orsini-PiocelleCéline ZecchiniCaroline CharlierLaurent ChouchanaPublished in: American journal of hematology (2023)